EC Healthcare (HKG:2138) recorded a profit attributable to equity shareholders of HK$14.1 million for the six months ended Sept. 30, higher than HK$6.7 million logged for the corresponding period last year, a Thursday filing with the Hong Kong Exchange said.
Earnings per share attributable to equity shareholders stood at HK$0.012 for the reporting period, compared with HK$0.006 recorded for the year-ago period.
The non-hospital medical service provider's revenue for the six months under review was HK$2.06 billion, 2.8% lower than HK$2.12 billion booked a year ago.
The board recommended an interim dividend of HK$0.010 per share for the reporting period, as compared with HK$0.005 per share a year earlier.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。